All filters
Slidesets
Lifestyle Modifications - Fraja Chiwanga, MD, MMed (Int.Med), MSc.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Management of Complications of Cirrhosis - Eva Justine Uiso, MD, MMED, MSc.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Management of Alcohol in Patients with Viral Hepatitis - Aleksander Krag, MD, PhD, MBA.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Pediatric Steatotic Liver Disease - Manal Hamdy El-Sayed, MD, PhD.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Management of NASH in Patients with Viral Hepatitis - Maria Buti, MD, PhD.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Prevalence and factors associated with MAFLD among adults with chronic hepatitis B infection in The Gambia - Bakary K. Dibba.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Sustainable Access to Diagnostics & Therapeutics for HBV - John C. Rwegasha,MBChB, MMED, FRCP (Lond), MSc.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Role of Multidisciplinary Approach in Resource Limited Settings SOLDA Supported Session.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Time to Initiation of Hepatitis B Treatment Is Reduced with the Use of the Xpert HBV DNA Kit - Hailemichael Desalegn.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Virological Characterization of Treatment Failures and Retreatment Outcomes in People Living with “Unusual” HCV Genotype 1 Subtypes - Erwan Vo Quang.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
WHO HBV Guidelines - New Directions for Hepatitis B Treatment and Care and Implications for Africa - Philippa Easterbrook, MD, FRCP, MPH, DTM&H.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Videos
New Therapeutic Combination Trials – What Are Their Potential to Achieve a Cure? - Mark Sulkowski
Presented at:
International Workshop on HBV Cure 2022
Videos
What to Watch Preclinical Therapeutics with Novel Mechanisms of Action - Massimo Levrero
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Bulevirtide - Data from Real World Usage after Approval in Europe - John Flaherty
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Development of Assembly Next Generation Core Inhibitors - Grace Wang
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Evidence of T Cell Restoration after siRNA Therapy - Emily Thi
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Cam-N Jnj-6379. Lessons Learned From Reef-1 and -2 Studies - Michael Biermer
Presented at:
International Workshop on HBV Cure 2022
Slidesets
How HBV RNA and HBcrAg Relate to cccDNA Transcriptional Activity - Barbara Testoni
Presented at:
International Workshop on HBV Cure 2022
Slidesets
HBV-Specific T Cell Profile Associated with Functional Cure - Georg Lauer
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Why We Should Be Careful Using NA Withdrawal as a Therapeutic Option - Pietro Lampertico
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Therapy Induced Flares Associated With HBsAg Decline - Man-Fung Yuen
Presented at:
International Workshop on HBV Cure 2022
Slidesets
Toxicity Profiles of Checkpoint Inhibition, What to Expect and When to Be Concerned - Morven Cunningham
Presented at:
International Workshop on HBV Cure 2022